Novelix Pharmaceuticals Ltd Share Price Today - Novelix Pharmaceuticals Ltd Stock Price Live NSE/BSE

Novelix Pharmaceuticals Ltd

NSE: BSE: 536565

₹55.95

(1.18%)

Fri, 08 May 2026, 03:17 pm

MTF 5xInvest in Novelix Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap978.16M

PE Ratio45.95

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Novelix Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
58.64
Net Profit
-2.03
P/B
0.97
Sector P/E
34.49
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.69
ROCE (Industry)
13.46
RONW (Industry)
12.65
ROE
0
ROCE
0
Debt/Equity
0.01
EPS (TTM)
0
Dividend Yield
0
Book Value
12.51
Interest Cover
-33

Analysis

all

Pros

Trimurthi is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Trimurthi has been profitable on average in the past, therefore cash runway is not a concern.
Trimurthi has been profitable on average in the past, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 13x debt.
Trimurthi's cash and other short term assets cover its long term commitments.

Cons

Unable to calculate sustainability of dividends as Trimurthi has not reported any payouts.
Unable to evaluate Trimurthi's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Trimurthi's dividend against the top 25% market benchmark as the company has not reported any payouts.
Operating cash flow is negative therefore debt is not well covered.
The level of debt compared to net worth has increased over the past 5 years (0% vs 7.6% today).

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	49.43	51.98	54.82	52.75	66.56
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	50.57	48.02	45.18	47.25	33.44
Government	0	0	0	0	0

Technical Analysis

RSI

47.60

MACD

-0.27

50 DMA

55.84

200 DMA

52.06

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	87.85	72.06	63.53	56.27	47.74	40.48	24.69
Fibonacci	72.06	66.03	62.30	56.27	50.24	46.51	40.48
Camarilla	59.34	57.89	56.45	56.27	53.55	52.11	50.66

Pivots Level: Classic

+31.58

87.85

+15.79

72.06

+7.26

63.53

56.27

Pivot Point

LTP: 54.67

-8.53

47.74

-15.79

40.48

-31.58

24.69

Moving Average

SMAEMA

Period

Value

10-EMA
55.19
20-EMA
55.40
30-EMA
55.61
50-EMA
56.02
100-EMA
55.54
200-EMA
50.46

Announcement Date	Purpose	Action
12 Feb 2026	board-meetings	Quarterly Results
11 Dec 2025	egm
13 Nov 2025	board-meetings	Quarterly Results
15 Aug 2025	agm
12 Apr 2025	egm
21 Oct 2024	egm
02 Sept 2024	agm
24 Aug 2023	agm
05 Dec 2022	egm
28 Jul 2022	agm

Novelix Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Lupin Ltd

Cipla Ltd

Divis Laboratories Ltd

Novelix Pharmaceuticals Ltd About

Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1994

Headquarters

CEO

Employees

Contact

Website

http://www.trimurthidrugs.com

info@trimurthidrugs.com

Phone

91-40-24757370

Location

4-4-231/1/2/ABC Inderbagh, Sultan Bazar, Hyderabad, Telangana, 500095

Year	History
2009	The Company has been appointed as authorised distributors on all India level for M/s. Livewell Food products and M/s. ABLE, Pharma.
2010	The Company has recommended the dividend of 3% on the equity shares.
2011	The Company has recommended the dividend of 3% on the equity shares. The Company started marketing of its products in the state of Assam.
2012	The Company has entered into a Manufacturing Agreement with M/s. Bharat Parenterals Limited, Vadodara, Gujrat for exclusive manufacture of Company's 12 products for export. The Company entered into Distribution Agreement with Zyanya Global Pte Limited, Vietnam for selling the Company's Products in Vietnam. The Company has recommended the dividend of 3% on the equity shares.
2024	The Company name has changed to Novelix Pharmaceuticals Ltd. from Trimurthi Ltd.

Client Name	Order Side	QTY	Avg Price	Date
MEDO CAPITAL SERVICES PRIVATE LIMITED	Sell	125000	43.29	03 Jul 2025
INDUS CAPITAL PRIVATE LIMITED	Buy	57133	8.55	12 Jan 2022
BEKAE PROPERTIES PRIVATE LIMITED	Sell	57133	8.55	12 Jan 2022
KIRAN BHANGADIA	Buy	43000	7.11	09 May 2014
ARUN KUMAR BHANGADIA	Buy	50000	4.66	21 Feb 2014
ARUN KUMAR BHANGADIA	Buy	60000	4.68	20 Feb 2014
SHREEVISHWAMURTE TRADINVEST PRIVATE LIMITED	Buy	61009	5.38	14 Feb 2014
PREETI GAGAN ARORA	Sell	71453	6.38	07 Feb 2014
PREETI GAGAN ARORA	Buy	71453	6.27	07 Feb 2014
SHREEVISHWAMURTE TRADINVEST PRIVATE LIMITED	Sell	66448	7.38	31 Jan 2014

Novelix Pharmaceuticals Ltd News

Novelix Pharma Files Q4FY26 SEBI Compliance Certificate

Novelix Pharmaceuticals Limited submits mandatory quarterly certificate under SEBI Depositories Regulations for quarter ended March 31, 2026, confirming proper dematerialisation procedures.

09 Apr 2026

companies

Novelix Pharmaceuticals Files SEBI Disclosure for Share Allotment

Novelix Pharmaceuticals submitted regulatory disclosure under SEBI Takeover Regulations for substantial acquisition by SRINIDHI FINE-CHEMICALS LLP and NARAHARI BELIDE through preferential allotment.

02 Apr 2026

companies

Novelix Pharma Reconstitutes Board Committees

Novelix Pharmaceuticals Limited reconstituted its Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee in a board meeting held on March 30, 2026.

01 Apr 2026

companies

Novelix Pharma Allots 11.50 Lakh Shares via Warrant Conversion

Novelix Pharmaceuticals allotted 11,50,000 equity shares at Rs. 20 each through warrant conversion, raising Rs. 1.73 crore from promoter group investors SRINIDHI FINE-CHEMICALS LLP and NARAHARI BELIDE.

31 Mar 2026

companies

Novelix Pharma Converts Warrants, Director Resigns

Novelix Pharmaceuticals allots 11,50,000 equity shares through warrant conversion raising Rs. 1,72,50,000, while Non-Executive Director Jivamohan Divakar Valluri resigns due to personal commitments.

31 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800